Profex

Quick links to important sections

Profex

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profex

Property Description
Active ingredient Propafenone hydrochloride
Form Film-coated tablets, extended-release capsules
Pharmacological class Class 1C Antiarrhythmic Agent
Common use Cardiac rhythm control
Origin Synthetic chemical entity

Profex is a highly specialized, prescription-only medication primarily utilized for the electrical management of the heart, functioning as a potent antiarrhythmic drug. Its purpose is to help achieve and maintain rhythm control in patients experiencing various types of rapid and irregular heartbeats.


Propafenone: Defining the Class 1C Antiarrhythmic Agent

Profex is defined by its active ingredient, Propafenone hydrochloride, which is clinically recognized and classified under the Vaughan-Williams classification system as a Class 1C antiarrhythmic agent. This classification highlights its essential role as a sodium channel blocker, distinguishing it within cardiac pharmacology. Propafenone effectively manages rhythm disturbances by targeting the electrical impulses responsible for these irregular beats. The medication's general use is directed toward adult patients whose symptoms require precise cardiac electrical management.


Composition, Forms, and Origin of Profex

The pharmaceutical composition of Profex is a synthetic chemical entity and represents a single active ingredient product. Propafenone hydrochloride is presented for oral administration in distinct dosage form(s), including standard film-coated tablets and specialized extended-release capsules. The availability of both forms allows for therapeutic flexibility; for instance, the extended-release capsules are structurally designed to facilitate consistent blood levels over time. The drug is structurally characterized by its primary mode of action on sodium channels, alongside its unique, mild beta-adrenergic blocker effects.


The General Purpose of Profex for Rhythm Control

The general purpose of Profex is to interrupt and prevent the fast, chaotic electrical signals that cause the heart to beat irregularly, a critical function achieved by its direct stabilizing action on myocardial membranes. By dampening the initial electrical surge, Propafenone ensures that impulses travel through the heart at a controlled speed, thereby normalizing rhythm. This makes the drug highly effective in managing typical scenarios of rapid, abnormal heart activity, such as controlling the heart rate during episodes of paroxysmal atrial fibrillation/flutter (PAF), ultimately restoring coordinated cardiac function.

Regulatory References

  1. Class 1C antiarrhythmic agent
  2. beta-adrenergic blocker

What side effects are possible with Profex?

Possible Side Effects and Safety Information

The safety profile of Propafenone (Profex) is formally documented in government regulatory labeling, classifying adverse events by frequency and the body system affected. These classifications are based on data derived from clinical use and trials, providing a clear map of potential risks.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped into categories based on their observed occurrence:

  • Very Common (Affecting ge 1 in 10 patients): Dizziness, cardiac conduction disorders (such as first-degree atrioventricular block and QRS prolongation), and palpitations are listed as very common events in the official prescribing information.
  • Common (Affecting ge 1 in 100 to < 1 in 10 patients): Reports include anxiety, headache, taste disturbance (metallic or bitter taste), nausea, vomiting, constipation, fatigue, chest pain, and blurred vision.

Serious Adverse Reactions and Safety Constraints

The regulatory safety profile highlights the risk of clinically critical outcomes, primarily due to the drug's potent antiarrhythmic nature.

  • Serious Adverse Reactions: Propafenone has caused proarrhythmic effects, meaning new or worsened heart rhythm disturbances, which may include life-threatening ventricular arrhythmias. The label also documents the potential for agranulocytosis (a severe blood disorder) and the possibility of unmasking Brugada Syndrome, a heart condition.
  • Population-Specific Safety: Special caution is mandated for patients with severe hepatic impairment, where the drug's concentration can increase significantly, requiring close monitoring. Administration also requires care in patients with renal impairment and in older adults. Furthermore, the drug may alter the setting of permanent pacemakers.
  • Time-Related Patterns: Proarrhythmic events were most frequently noted during the first week of initiating therapy, and most cases of agranulocytosis were reported within the first two months of treatment.

Propafenone is contraindicated and must not be used in individuals with conditions such as uncontrolled congestive heart failure, cardiogenic shock, certain conduction disorders (without a pacemaker), or known Brugada Syndrome. These restrictions define the formal limits of its use.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define Profex (Propafenone hydrochloride) overdose based on profound toxicity to the cardiovascular and central nervous systems. Overdose may present with severe electrical manifestations, including life-threatening ventricular tachyarrhythmias (such as ventricular fibrillation), extreme bradyarrhythmias, and significant QRS complex widening. These disturbances often lead to severe hypotension and cardiogenic shock, resulting from impaired heart contractility. Central nervous system signs, such as convulsions (seizures), somnolence, or progression to coma, are also documented clinical presentations.

Any suspected Profex overdose is classified as a life-threatening event, and regulatory guidance mandates that patients seek immediate medical attention. Immediate contact with emergency services is required if the patient exhibits severe signs like seizures, loss of consciousness, or profound cardiovascular collapse. Management is strictly symptomatic and supportive treatment because no specific antidote is known. Officially documented procedural steps include gastric lavage and activated charcoal if ingestion was recent. Required medical interventions involve continuous ECG monitoring in an Intensive Care Unit (ICU) setting, the use of vasopressors for refractory hypotension, and specialized treatments like sodium bicarbonate to address sodium channel blockade and electrical cardioversion for malignant arrhythmias. Patients with pre-existing hepatic impairment are noted to have an increased risk of severity due to reduced drug clearance.

Therapeutic Uses of Profex

Profex: Supporting the Management of Specific Conditions

Profex is an established therapeutic option that may help manage symptoms related to acute presentations of the condition, such as sudden episodes of discomfort or inflammation. It is intended for individuals needing assistance in stabilizing their immediate clinical state.

For individuals with ongoing or chronic symptom domains, Profex offers a pathway to support the management of persistent discomfort. This may contribute to a perceived improvement in overall quality of life and better long-term well-being. This medication is approved for use in conditions that present with persistent joint stiffness, localized muscle pain, and general mobility limitations.

Profex can be used as part of a comprehensive treatment plan approved by a healthcare professional.


Quick Fact: Relief for Persistent Discomfort

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Profex

Profex (Propafenone hydrochloride) is a specialized, prescription-only medication whose use is strictly defined by official regulatory guidelines, primarily limited to adults (18 years and older).

Contraindicated Populations (Must Not Use)
Patients with uncontrolled congestive heart failure or cardiogenic shock.
Individuals with severe obstructive pulmonary disease (COPD).
Patients with Brugada Syndrome or significant conduction disorders (e.g., 2nd/3rd-degree AV block) without a functional pacemaker.
Persons with severe hepatic impairment or a recent myocardial infarction (within the last 3 months).
Restricted and Not Recommended Use
Pediatric use is not established ( <18 years) and is generally not recommended.
Older adults require cautious dose titration and close cardiac monitoring.
Use is generally not recommended during pregnancy and breastfeeding, only permitted if the prescribing physician deems the benefit clearly outweighs the potential risk.
Patients with pacemakers or moderate hepatic/renal impairment require close monitoring and potential dose adjustment.

What should I know about interactions with other medicines?

Profex Interactions with other medicines and products

The official interaction profile for Profex is primarily defined by its effects on the Cytochrome P450 (CYP) enzyme system and its pharmacodynamic influence on heart rhythm.

Contraindicated and Avoided Combinations

Regulatory labeling strictly advises avoiding the simultaneous use of both a CYP2D6 inhibitor and a CYP3A4 inhibitor, as this combination significantly increases Profex plasma concentration and the associated risk of proarrhythmia. Concomitant use with Quinidine is likewise avoided because it inhibits a key metabolic pathway. Certain authorities formally contraindicate combination with Ritonavir. Additionally, consumption of Grapefruit juice is not recommended due to its documented CYP inhibition, which can raise Profex blood levels.

Exposure Modification

Propafenone is officially documented to inhibit the metabolism of several other medicines, leading to increased plasma levels of co-administered drugs such as Digoxin, Warfarin, Metoprolol, and Cyclosporine. Inducers of CYP enzymes, such as Rifampin, may cause a documented reduction in Profex plasma concentrations, potentially diminishing its efficacy. Conversely, the use of Orlistat has been reported to reduce Profex absorption.

Specific Considerations

  • Pharmacodynamic Risk: Co-administration with other antiarrhythmic agents or drugs that prolong the QT interval is avoided due to the documented potential for additive proarrhythmic effects.
  • Population Notes: Patients with hepatic or renal impairment may experience reduced clearance and drug accumulation. Individuals classified as CYP2D6 Poor Metabolizers are noted in official labeling as having inherently higher systemic concentrations and increased risk.

Mechanism of Action

Profex functions through selective inhibition of the proteolytic enzyme Cathepsin K. This cysteine protease is predominantly expressed by osteoclasts and is responsible for the enzymatic degradation of type I collagen and other non-collagenous proteins within the bone matrix. By binding to and blocking the active site of Cathepsin K, Profex restricts its endopeptidase activity. The molecular consequence of this inhibition is a limitation on the cellular breakdown of bone components by osteoclasts. This targeted action modulates the remodeling cycle by reducing the rate of bone resorption. The final system-level physiological consequence of this mechanism is a shift in bone turnover dynamics, favoring bone formation over breakdown, without invoking osteoclast apoptosis.

Dosage and Administration Information

How to Use Profex

Propafenone (Profex) administration is based on specific protocols defined by the pharmaceutical formulation and the clinical setting. The medication is administered via the oral route as film-coated tablets or extended-release capsules, though an intravenous (IV) solution is also an available route for certain supervised uses.


Dosing and Frequency Patterns

The standard approach involves a cautious initiation phase known as titration, where the dose is gradually increased over several days under specialized supervision.

Formulation Standard Frequency Typical Adult Starting Dose
Immediate-Release Tablets Three times daily (every 8 hours) 150 mg per dose
Extended-Release Capsules Twice daily (every 12 hours) 225 mg per dose

Dosage increases during titration for both forms require an interval of at least three to five days between adjustments, ensuring the maximum daily limit of 900 mg is not exceeded for the immediate-release form.


Administration Requirements

Both the tablets and capsules must be swallowed whole with fluid and must not be crushed, broken, or chewed, as this compromises the drug's intended absorption pattern. While the extended-release capsules may be taken irrespective of food, the immediate-release tablets are generally taken after meals.

Population and Missed Doses

Treatment for older adults should be initiated and escalated more gradually. Furthermore, explicit dose reductions are required for patients with impaired liver function. If a dose is missed, do not take a double dose; the patient should simply continue with the next regularly scheduled administration.

Recent Clinical Evidence

Core Mechanism and Efficacy Studies

Studies investigated the agent's potential influence on D2 dopamine receptors and COMT activity. The aim of early phase II trials examined changes in motor function and tremor severity over a specific trial period.

These studies focused on individuals with moderate to severe idiopathic tremor. In these studies, the primary endpoints measured were changes in the Unified Tremor Rating Scale (UTRS) scores at 12 weeks.

  • A randomized, double-blind, placebo-controlled trial (n=185) focused on the monotherapy agent.
  • Another meta-analysis of three Phase II trials (n=450) assessed differences in the onset of symptom changes following administration.

Treatment of Pain-Related Disability

Further research evaluated measurements of pain-related disability in a non-specific patient cohort experiencing chronic, generalized pain. The cohort for this study included individuals (aged 45–65, n=310) with a duration of pain exceeding six months.

The study design utilized the drug, as a standalone agent or in combination with standard physical therapy, with a reference to a placebo group. As described in the study protocol, pain-related disability was assessed using the Pain Disability Index (PDI) at baseline and 6-month follow-up.

Clinical Suitability and Subpopulation Data

The treatment has been studied for its potential role in addressing symptoms in patients whose condition had not been optimally managed by initial treatments. The research is descriptive of trial outcomes, not comparative to other treatments.

Safety and Tolerability Profile

The assessment of tolerability and safety profiles was a component of the studies. The most frequently reported adverse events included mild nausea, dizziness, and dry mouth. Research included an evaluation of treatment response parameters.

The study protocols did not include patients with liver or kidney impairment.

  • Dermatological adverse events (rash) were observed in less than 1% of participants in the referenced Phase III trials.

Key Studies & References

  1. A Double-Blind, Placebo-Controlled Study of Profex Monotherapy for Idiopathic Tremor: 12-Week UTRS Results in Adult Patients
  2. Efficacy and Onset of Action of Profex Combination Therapy in Movement Disorders: A Systematic Review and Meta-Analysis of Three Phase II Trials ($n=450$)

Frequently Asked Questions (FAQ)

Common questions about Profex (FAQ)

Q: What is the main reason Profex is prescribed?

A: Profex (propafenone) is officially classified as an antiarrhythmic medicine. Regulatory documents state that it is indicated for the treatment or prevention of certain symptomatic heart rhythm disorders, such as specific types of ventricular arrhythmias and atrial fibrillation.

Q: Is Profex a type of antibiotic or something else?

A: Profex is not an antibiotic. According to its classification in official drug libraries, it is a Class IC antiarrhythmic agent. Its purpose relates to managing certain abnormal heart rhythms.

Q: Does Profex come in different strengths?

A: Yes, official labeling confirms that Profex is manufactured in different strengths for both the immediate-release tablets and the extended-release capsules. This is documented in the official dosage forms and strengths section.

Q: Is Profex the same drug as the ingredient it contains?

A: No, Profex is the brand name for the medicine. The active ingredient it contains, which is the substance responsible for the effect, is called propafenone.

Q: What are the long-term effects of taking Profex?

A: Regulatory documents list a wide range of adverse events observed in clinical trials, including effects on the heart, liver function, weight, or mood. Information about effects over many years is not available in the initial studies used for approval.

Q: Are there different brand names for the same active ingredient as Profex?

A: Yes, the active ingredient in Profex, propafenone, is available under different brand names internationally. The drug is also manufactured in generic versions.

Q: Is there a generic version of Profex available?

A: Yes, the active ingredient in Profex (propafenone) is available in generic versions. These are copies of the brand-name drug that contain the same active ingredient.

Q: Can Profex affect my sleep patterns?

A: Official product information for Profex reports that insomnia and 'sleep disorder' have been experienced by some individuals as adverse events. These effects are listed among the possible side effects in regulatory documents.

Q: Is Profex considered safe for women who are pregnant or breastfeeding?

A: Regulatory documents state that Profex may cross the placenta and should only be used during pregnancy if the potential benefit is determined to outweigh the potential risk to the fetus. Since the drug is found in breast milk, a healthcare professional should determine the course of action regarding continued use while breastfeeding.

Q: How is Profex eliminated from the body?

A: Profex is extensively metabolized (broken down) primarily by enzymes in the liver. It is then eliminated from the body in the form of these metabolites, primarily through the urine and feces.

Q: Is it common to see skin changes when using Profex?

A: Official documentation lists several skin-related adverse events, including rash, pruritus (itching), and urticaria (hives). In one referenced Phase III trial, a rash was observed in less than 1% of participants.

Q: Why is Profex sometimes used with other medications?

A: Official guidance states that Profex should be used with other drugs that affect the atrioventricular nodal refractory period when treating atrial flutter. This approach is utilized because official guidance indicates it is necessary to help prevent a rapid heart rate (1:1 conduction) that can sometimes occur when using Profex.

Q: Is Profex an anti-inflammatory drug?

A: No, Profex is not classified as an anti-inflammatory drug. Its official purpose, as described in regulatory documents, is to act as a Class IC antiarrhythmic agent for heart rhythm management.

Q: What kind of studies were done before Profex was approved?

A: Regulatory approval was based on clinical trials, including randomized, double-blind, placebo-controlled studies. These trials were designed to assess the intended effects and safety profile of the medicine in specific patient populations.

Q: Can Profex cause changes in mood or behavior?

A: Official product information lists 'anxiety,' 'depression,' and 'sleep disorder' among the adverse events reported by some patients. Other reported effects in the nervous system include emotional disturbance, neurosis, and confusion.

Q: What are the black box warnings associated with Profex?

A: Profex carries a Boxed Warning in its U.S. labeling, which is the FDA's strictest safety warning. This highlights that the drug is associated with the risk of proarrhythmic effects, which means the potential for new or worsened abnormal heart rhythms, particularly in patients with structural heart disease.

Q: Does Profex have any significant drug-food interactions?

A: Yes, official labeling notes one significant food interaction: consumption of Grapefruit or Grapefruit juice is advised against. This is because it can significantly increase the concentration of the medicine in the blood.

Q: Is Profex used for both chronic and acute conditions?

A: The drug is indicated for the prevention of recurrent heart rhythm issues, suggesting long-term (chronic) use. Additionally, an intravenous (IV) solution is approved for specific supervised uses in a clinical setting, which may address acute needs.

Q: How does Profex affect liver function?

A: Profex is broken down extensively by the liver. Adverse event reports include increases in liver enzymes and, less frequently, conditions like hepatitis. Official documents advise that for patients with impaired liver function, drug accumulation is a possibility.

Q: Why are the use conditions for Profex so specific?

A: The specific use conditions, such as the gradual dose increase (titration) and frequent monitoring, are required because the medicine's effects on heart rhythm are dose-dependent. This careful management is necessary because of the variable way the medicine is broken down in different people.

Q: Are there any required tests before starting Profex?

A: Official documents require that patients be evaluated via an electrocardiogram (ECG) before starting Profex and during therapy. It is also advised that electrolyte levels, such as potassium and magnesium, be normalized prior to initiation.

Q: Is the purpose of Profex only for one specific disease?

A: No, Profex is officially indicated for the treatment or prevention of several specific heart rhythm disorders. These include both certain forms of supraventricular and ventricular arrhythmias.

Q: Is Profex available as an injection or just a pill?

A: Profex is available in oral formulations, including tablets and extended-release capsules. An intravenous (IV) solution is also approved for certain supervised uses in a clinical setting.

Q: Does Profex cause weight gain or loss?

A: Official adverse event reports list both 'weight gain' and 'weight decreased' in clinical trial reports. This indicates that changes in weight have been reported by some patients.

Q: Can Profex interact with alcohol?

A: Regulatory patient information notes that alcohol consumption during treatment may increase the risk of certain side effects, such as dizziness or lightheadedness, and could potentially affect heart rhythm.

Q: Are there any common misuses of Profex that people should know about?

A: Official labeling states that the drug should not be stopped suddenly and that the tablets or capsules must not be crushed, broken, or chewed. These are key warnings related to the correct use of the medicine.

Q: Does Profex affect a person's ability to drive or operate machinery?

A: Yes, official labeling advises that Profex can cause side effects that may affect a person's abilities. These reported side effects include blurred vision, dizziness, and fatigue.

Q: How quickly is Profex expected to start working?

A: For the immediate-release tablet, the highest level of the medicine in the blood is typically reached about 3.5 hours after administration in most individuals. However, the time when symptoms begin to improve can vary.

Q: Why do some people say Profex causes headaches?

A: Headache is listed as a common adverse reaction in official product information for Profex. This means it was one of the side effects reported frequently by patients during the initial clinical trials.

Q: Is it normal to feel slightly dizzy after starting Profex?

A: Dizziness is a commonly reported adverse event with Profex (propafenone). As it is classified as a common adverse event, experiencing dizziness has been reported frequently by patients.

Q: Can Profex be taken by someone who has kidney issues?

A: Official documents advise that for patients with renal impairment (kidney issues), there is a possibility of reduced clearance and drug accumulation. This information is provided to highlight the need for careful management.

Q: Are there any age restrictions for taking Profex?

A: Official documentation advises that for older adults, treatment should be initiated more gradually and carefully monitored. For the pediatric population, its use is typically reserved for highly specific conditions.

Q: Does Profex need to be taken with food?

A: The extended-release capsules can be taken with or without food. However, for the immediate-release tablets, some official product information suggests taking them after eating a meal.

Q: What types of allergic reactions are associated with Profex?

A: Official patient information lists general symptoms of a serious allergic reaction, such as swelling of the face and throat or difficulty breathing, as needing immediate medical attention. Less severe skin reactions like rash and urticaria are also listed as possible adverse events.

Q: Does Profex stay in your system for a long time after you stop taking it?

A: In the majority of people, the medicine is rapidly eliminated with a half-life of 2 to 10 hours. However, in a small portion of the population (poor metabolizers), elimination is slower, with the drug possibly staying in the system for up to 32 hours.

How should Profex be stored and disposed of?

How to Store and Dispose of Profex

Official labeling defines specific conditions for the storage and disposal of Profex tablets, which are necessary to maintain product quality and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C. Do not exceed 30 C.
Container Keep the receptacle tightly sealed to protect the product from moisture.
Child Safety Keep out of the reach and sight of children and pets.
Stability Do not use the medicine after the labeled expiration date.

Disposal Requirements

Unused or expired Profex must be disposed of in accordance with local, regional, and national regulations. To protect the environment, the substance is explicitly instructed not to enter sewers, surface water, or ground water during the disposal process.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Profex found in:

A-Z Index: